Lensar (LNSR) Share-based Compensation (2019 - 2026)
Lensar's (LNSR) quarterly Share-based Compensation came in at $690000.0 in Q1 2026, up 5.5% year-on-year from $654000.0 in Q1 2025, and down 20.96% on a QoQ basis from $873000.0 in Q4 2025.
Lensar (LNSR) Share-based Compensation (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Share-based Compensation data on file, last reported at $690000.0 in Q1 2026.
- On a quarterly basis, Share-based Compensation rose 5.5% year-over-year to $690000.0 in Q1 2026; TTM through Mar 2026 was $3.2 million, a 19.2% increase from a year earlier, with the FY2025 full-year figure at $3.1 million, up 17.94% from the prior year.
- Share-based Compensation for Q1 2026 stood at $690000.0, down from $873000.0 in the prior quarter.
- Over the last five years, Share-based Compensation for LNSR reached as high as $1.8 million in Q2 2023 and fell as low as -$1.6 million in Q4 2023.
- Historically, Share-based Compensation has averaged $956000.0 across 5 years, with a median of $850000.0 in 2025.
- Across the five-year window, Share-based Compensation slumped 193.22% in 2023 and jumped 141.9% in 2024, its largest moves.
- Year by year, Share-based Compensation stood at $1.7 million in 2022, then slumped by 193.22% to -$1.6 million in 2023, then soared by 141.9% to $662000.0 in 2024, then surged by 31.87% to $873000.0 in 2025, then declined by 20.96% to $690000.0 in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $690000.0 in Q1 2026, $873000.0 in Q4 2025, and $850000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lensar | 70.05 Mn | 72.73 Mn | 6.38 Mn | 690,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 690,000.00 |
| Mar 31, 2026 | 690,000.00 |
| Dec 31, 2025 | 873,000.00 |
| Dec 31, 2025 | 873,000.00 |
| Sep 30, 2025 | 850,000.00 |
| Sep 30, 2025 | 850,000.00 |
| Jun 30, 2025 | 766,000.00 |
| Jun 30, 2025 | 766,000.00 |
| Mar 31, 2025 | 654,000.00 |
| Mar 31, 2025 | 654,000.00 |
| Dec 31, 2024 | 662,000.00 |
| Dec 31, 2024 | 662,000.00 |
| Sep 30, 2024 | 668,000.00 |
| Sep 30, 2024 | 668,000.00 |
| Jun 30, 2024 | 683,000.00 |
| Jun 30, 2024 | 683,000.00 |
| Mar 31, 2024 | 652,000.00 |
| Mar 31, 2024 | 652,000.00 |
| Dec 31, 2023 | -1.58 Mn |
| Dec 31, 2023 | -1.58 Mn |